These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Reduced benzodiazepine sensitivity in patients with panic disorder: comparison with patients with obsessive-compulsive disorder and normal subjects. Roy-Byrne P; Wingerson DK; Radant A; Greenblatt DJ; Cowley DS Am J Psychiatry; 1996 Nov; 153(11):1444-9. PubMed ID: 8890678 [TBL] [Abstract][Full Text] [Related]
5. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Sundström I; Ashbrook D; Bäckström T Psychoneuroendocrinology; 1997 Jan; 22(1):25-38. PubMed ID: 9141149 [TBL] [Abstract][Full Text] [Related]
6. Benzodiazepine pharmacodynamics: utility of eye movement measures. Roy-Byrne PP; Cowley DS; Radant A; Hommer D; Greenblatt DJ Psychopharmacology (Berl); 1993; 110(1-2):85-91. PubMed ID: 7870903 [TBL] [Abstract][Full Text] [Related]
7. Effects of diphenhydramine on human eye movements. Hopfenbeck JR; Cowley DS; Radant A; Greenblatt DJ; Roy-Byrne PP Psychopharmacology (Berl); 1995 Apr; 118(3):280-6. PubMed ID: 7617820 [TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic approaches to benzodiazepine action in man. Hommer DW; Matsuo V; Wolkowitz OM; Weingartner H; Paul SM Psychopharmacol Ser; 1987; 3():52-61. PubMed ID: 3029755 [No Abstract] [Full Text] [Related]
9. Eye movement effects of diazepam in sons of alcoholic fathers and male control subjects. Cowley DS; Roy-Byrne PP; Radant A; Hommer DW; Greenblatt DJ; Vitaliano PP; Godon C Alcohol Clin Exp Res; 1994 Apr; 18(2):324-32. PubMed ID: 8048734 [TBL] [Abstract][Full Text] [Related]
10. The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration. Bittencourt PR; Wade P; Smith AT; Richens A Br J Clin Pharmacol; 1981 Oct; 12(4):523-33. PubMed ID: 6794587 [TBL] [Abstract][Full Text] [Related]
11. Effects of diazepam and buspirone on reaction time of saccadic eye movements. Fafrowicz M; Unrug A; Marek T; van Luijtelaar G; Noworol C; Coenen A Neuropsychobiology; 1995; 32(3):156-60. PubMed ID: 8544973 [TBL] [Abstract][Full Text] [Related]
12. Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Ball DM; Glue P; Wilson S; Nutt DJ Psychopharmacology (Berl); 1991; 105(3):361-7. PubMed ID: 1665920 [TBL] [Abstract][Full Text] [Related]
13. Specific oculomotor deficit after diazepam. I. Saccadic eye movements. Rothenberg SJ; Selkoe D Psychopharmacology (Berl); 1981; 74(3):232-6. PubMed ID: 6791230 [TBL] [Abstract][Full Text] [Related]
14. A comparison of the psychotropic profiles of tofisopam and diazepam. Bond A; Lader M Eur J Clin Pharmacol; 1982; 22(2):137-42. PubMed ID: 6124424 [TBL] [Abstract][Full Text] [Related]
15. The effects of alprazolam, quazepam and diazepam on saccadic eye movements, parameters of psychomotor function and the EEG. Blom MW; Bartel PR; de Sommers K; Van der Meyden CH; Becker PJ Fundam Clin Pharmacol; 1990; 4(6):653-61. PubMed ID: 1982881 [TBL] [Abstract][Full Text] [Related]
16. Intravenous diazepam fails to change growth hormone and cortisol secretion in humans. Breier A; Charney DS; Heninger GR Psychiatry Res; 1986 Aug; 18(4):293-9. PubMed ID: 3749390 [TBL] [Abstract][Full Text] [Related]